These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 24894557

  • 1. Synthesis and antiangiogenic activity of 6-amido-2,4,5-trimethylpyridin-3-ols.
    Lee H, Banskota S, Kim DG, Been JH, Jin YJ, Gautam J, Jang H, Nam TG, Kim JA, Jeong BS.
    Bioorg Med Chem Lett; 2014 Jul 15; 24(14):3131-6. PubMed ID: 24894557
    [Abstract] [Full Text] [Related]

  • 2. 6-Amino-2,4,5-trimethylpyridin-3-ols: a new general synthetic route and antiangiogenic activity.
    Kim DG, Kang Y, Lee H, Lee EK, Nam TG, Kim JA, Jeong BS.
    Eur J Med Chem; 2014 May 06; 78():126-39. PubMed ID: 24681390
    [Abstract] [Full Text] [Related]

  • 3. Pyridoxine-derived bicyclic amido-, ureido-, and carbamato-pyridinols: synthesis and antiangiogenic activities.
    Lee H, Kim DG, Banskota S, Lee YK, Nam TG, Kim JA, Jeong BS.
    Org Biomol Chem; 2014 Nov 21; 12(43):8702-10. PubMed ID: 25255328
    [Abstract] [Full Text] [Related]

  • 4. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
    Conconi MT, Marzaro G, Urbani L, Zanusso I, Di Liddo R, Castagliuolo I, Brun P, Tonus F, Ferrarese A, Guiotto A, Chilin A.
    Eur J Med Chem; 2013 Sep 21; 67():373-83. PubMed ID: 23900004
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in vivo.
    Luo K, Bao Y, Liu F, Xiao C, Li K, Zhang C, Huang R, Lin J, Zhang J, Jin Y.
    Eur J Med Chem; 2019 Oct 01; 179():805-827. PubMed ID: 31295714
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis, and biological evaluation of novel deguelin-based heat shock protein 90 (HSP90) inhibitors targeting proliferation and angiogenesis.
    Chang DJ, An H, Kim KS, Kim HH, Jung J, Lee JM, Kim NJ, Han YT, Yun H, Lee S, Lee G, Lee S, Lee JS, Cha JH, Park JH, Park JW, Lee SC, Kim SG, Kim JH, Lee HY, Kim KW, Suh YG.
    J Med Chem; 2012 Dec 27; 55(24):10863-84. PubMed ID: 23186287
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, and evaluation of 3,5-disubstituted 7-azaindoles as Trk inhibitors with anticancer and antiangiogenic activities.
    Hong S, Kim J, Seo JH, Jung KH, Hong SS, Hong S.
    J Med Chem; 2012 Jun 14; 55(11):5337-49. PubMed ID: 22575050
    [Abstract] [Full Text] [Related]

  • 8. Improvement of in vivo anticancer and antiangiogenic potential of thalidomide derivatives.
    da Costa PM, da Costa MP, Carvalho AA, Cavalcanti SM, de Oliveira Cardoso MV, de Oliveira Filho GB, de Araújo Viana D, Fechine-Jamacaru FV, Leite AC, de Moraes MO, Pessoa C, Ferreira PM.
    Chem Biol Interact; 2015 Sep 05; 239():174-83. PubMed ID: 26134001
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, structure-activity relationships and biological evaluation of barbigerone analogues as anti-proliferative and anti-angiogenesis agents.
    Wang G, Wang F, Cao D, Liu Y, Zhang R, Ye H, Li X, He L, Yang Z, Ma L, Peng A, Xiang M, Wei Y, Chen L.
    Bioorg Med Chem Lett; 2014 Jul 15; 24(14):3158-63. PubMed ID: 24863745
    [Abstract] [Full Text] [Related]

  • 10. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
    Gangjee A, Zeng Y, Ihnat M, Warnke LA, Green DW, Kisliuk RL, Lin FT.
    Bioorg Med Chem; 2005 Sep 15; 13(18):5475-91. PubMed ID: 16039863
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, characterization, cytotoxicity and antiangiogenic activity of copper(II) complexes with 1-adamantoyl hydrazone bearing pyridine rings.
    Rodić MV, Leovac VM, Jovanović LS, Spasojević V, Joksović MD, Stanojković T, Matić IZ, Vojinović-Ješić LS, Marković V.
    Eur J Med Chem; 2016 Jun 10; 115():75-81. PubMed ID: 27084495
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and structure-activity relationships of asymmetric dimeric β-carboline derivatives as potential antitumor agents.
    Guo L, Chen W, Cao R, Fan W, Ma Q, Zhang J, Dai B.
    Eur J Med Chem; 2018 Mar 10; 147():253-265. PubMed ID: 29448140
    [Abstract] [Full Text] [Related]

  • 13. Toward Angiogenesis Inhibitors Based on the Conjugation of Organometallic Platinum(II) Complexes to RGD Peptides.
    Zamora A, Gandioso A, Massaguer A, Buenestado S, Calvis C, Hernández JL, Mitjans F, Rodríguez V, Ruiz J, Marchán V.
    ChemMedChem; 2018 Sep 06; 13(17):1755-1762. PubMed ID: 29932312
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors.
    Guo L, Ma Q, Chen W, Fan W, Zhang J, Dai B.
    J Enzyme Inhib Med Chem; 2019 Dec 06; 34(1):375-387. PubMed ID: 30734606
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth.
    Xu F, Jia Y, Wen Q, Wang X, Zhang L, Zhang Y, Yang K, Xu W.
    Eur J Med Chem; 2013 Jun 06; 64():377-88. PubMed ID: 23644219
    [Abstract] [Full Text] [Related]

  • 16. Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment.
    Narise K, Okuda K, Enomoto Y, Hirayama T, Nagasawa H.
    Drug Des Devel Ther; 2014 Jun 06; 8():701-17. PubMed ID: 24944508
    [Abstract] [Full Text] [Related]

  • 17. New minor groove covering DNA binding mode of dinuclear Pt(II) complexes with various pyridine-linked bridging ligands and dual anticancer-antiangiogenic activities.
    Franich AA, Živković MD, Ilić-Tomić T, Đorđević IS, Nikodinović-Runić J, Pavić A, Janjić GV, Rajković S.
    J Biol Inorg Chem; 2020 May 06; 25(3):395-409. PubMed ID: 32162071
    [Abstract] [Full Text] [Related]

  • 18. The microtubule depolymerizing agent CYT997 causes extensive ablation of tumor vasculature in vivo.
    Burns CJ, Fantino E, Powell AK, Shnyder SD, Cooper PA, Nelson S, Christophi C, Malcontenti-Wilson C, Dubljevic V, Harte MF, Joffe M, Phillips ID, Segal D, Wilks AF, Smith GD.
    J Pharmacol Exp Ther; 2011 Dec 06; 339(3):799-806. PubMed ID: 21917561
    [Abstract] [Full Text] [Related]

  • 19. Trans-platinum(II)/(IV) Complexes with Acetylpyridine Ligands as Antivascular Agents in vitro: Cytotoxic and Antiangiogenic Potential.
    Lana F, Sandra A, Ana K, Radmila J, Biljana D, Siniša R.
    Anticancer Agents Med Chem; 2016 Dec 06; 16(12):1628-1639. PubMed ID: 27102278
    [Abstract] [Full Text] [Related]

  • 20. Novel 1,4-benzoxazine and 1,4-benzodioxine inhibitors of angiogenesis.
    Ilić M, Ilaš J, Dunkel P, Mátyus P, Boháč A, Liekens S, Kikelj D.
    Eur J Med Chem; 2012 Dec 06; 58():160-70. PubMed ID: 23124213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.